Coordinator for multiple gene sequencing on cancer tissue (FoundationOne, Cambridge, MA02141, USA), September 2017-Present
|
|
- Rachel Charles
- 5 years ago
- Views:
Transcription
1 CURRICULUM VITAE ET STUDIORUM NAME Veronica Varchetta DOB: 23/07/1987 POB: Rome Italy PRESENT TITLE AND AFFILIATION Oncology Assistant and Coordinator, Specific Research Area: Translational and Clinical Oncology Clinical Project Manager, Specific Research Area: Translational and Clinical Coordinator for Liquid Biopsy (SCED Solid Cancer Early Detection) in collaboration with University Tor Vergata, Rome and Bioscience Institute, San Marino Republic, January 2017-Present Coordinator for Liquid Biopsy (Free and CTC DNA sequencing molecular characterization for diagnosis and treatment) in collaboration with Genoma Group, Roma, April 2017-Present Coordinator for multiple gene sequencing on cancer tissue (FoundationOne, Cambridge, MA02141, USA), September 2017-Present CITIZENSHIP Italian LANGUAGE SPOKEN English C1+ HOME ADDRESS Via Londra 4, Ciampino, Roma, Italy Telephone: ; mobile: !1
2 OFFICE ADDRESS CaTheDra Medical Oncology Dept Villa Margherita, Rome, Italy , Viale di Villa Massimo, 48, Roma Telephone: Fax: EDUCATION Degree-Granting Education Degree in Political Science, University Niccolò Cusano, Rome, Italy (3 years Degree: 97/110), March 2013 Degree in Political Science, University Niccolò Cusano, Rome, Italy (Master Degree 100/110), July 2015 Master of Healthcare Management cum laude, University Niccolò Cusano, Rome, Italy, January 2018 Postgraduate Training in Medical Science Certification in Clinical Oncology Multidisciplinary Organization, April 2015, University Health Board, GIG CYMRU NHS WALES GCP Training Certificate, 2015 GCP Training Certificate, 2016 GCP Training Certificate, 2017 Training Specific Courses 2 Oncoworkshop in Nanotechnologies and Innovations: New landscapes in treatment of cancer disease, Bari, March 27-28, 2015 New supportive therapies in Oncology, Bologna, May 11-12, 2015 Methods and Strategies in Clinical Colorectal Cancer, Florence, May 14, 2015!2
3 The Biological Bases of new Target therapies in Lung Cancer. Lung Unit, Sharing the Experience, Rome, May 21, 2015 PRACTICE Meeting on Colorectal Cancer, Rome July 8, 2015 SABC Standing Advisory Board on Colorectal Cancer, Milan Jule 13, 2015 Grande Lung Slam meeting, Roma October, 2015 AIOM National Meeting, October, Convegno/Workshop NICSO, Milano, December, 2015 ASCO University Course, 2016 Gastrointestinal Cancer Symposium MOC Review, Total AMA PRA Category Credit Awarded: 2.00, San Francisco, Jan 2016 Consensus Conference sulla Global Care del Paziente con Tumore Testa/Collo Ricorrente Metastatico, Milan, 5/05/2016 Choosing Wisely nel trattamento del carcinoma colorettale, Rome May 15, 2016 Updates on Oncological Abdominal Surgery, Rome May 12-13, 2016 ASCO 2016 Annual Meeting, ASCO University Course, 2016 Annual Meeting Chicago June 2016 ASCO 2017 Annual Meeting, ASCO University Course, 2017 Annual Meeting Chicago June 2017 ASCO University Course, 2018 Gastrointestinal Cancer Symposium MOC Review, Total AMA PRA Category Credit Awarded: 2.00, San Francisco, Jan 2018 EXPERIENCE/SERVICE Oncology Assistant and Coordinator, Specific Research Area: Translational and Clinical!3
4 Oncology Clinical Project Manager, Specific Research Area: Translational and Clinical MERIT AWARDS Grant to take part to International PrIME Expert Practice in Pancreatic Cancer Meeting, Budapest, Sept 2017 Grant for Clinical Project Manager in Immunoncology at Sukumvit Hospital, Bangkok (NCI, Thailand) Center of Excellence for Cancer Treatment and Immunotherapy Research (CECTIR) SCIENTIFIC COORDINATION AT NATIONAL OR INTERNATIONAL CONFERENCES Change from laboratory to clinic trial: Ca.The.Dra. Meeting, Rome, June 26-27, 2015 Consensus Conference Regionale sulla Global Care del paziente con Tumore Polmonare: Chirurgia, Clinica e Biologia Molecolare, Le Evidenze Internazionali nelle Linee Guida e Percorsi Terapeutici in Regione Lazio, Regione Lazio, November, 2016 National Conference on Lung and Colorectal Cancer, San Camillo/Forlanini Hospitals, Rome, April 2018 PUBLICATIONS ORIGINAL ARTICLES 1) Mancuso A, Varchetta V, Montagnese F, Sibio S, Sica G, Muscaritoli M, Giordano G, Brandi R, Leone A., On Behalf CaTheDra Multidisciplinary Cancer Group, A pilot study of Abraxane (Nab Paclitaxel) as second or third-line therapy for metastatic K-Ras mutated pancreatic cancer patients, 2 Oncoworkshop in Nanotechnologies and Innovations: New landscapes in treatment of cancer disease, Bari, March 27-28, ) Mancuso A, Varchetta V, Montagnese F, Sibio S, Sica G, Muscaritoli M, Soda G, Brandi R, On Behalf CaTheDra Multidisciplinary Cancer Group, PD-1 Expression and Regorafenib Clinical Efficacy on Refractory Pancreatic Cancer Patient, Chicago, May 2016, Abstr. E15684!4
5 3) Varchetta V, Campanella C, Caggiati A, Granati L and Mancuso A, Recurrence of venous thromboembolism among non small cell lung cancer patients treated with EGFR inhibitor, ICTHIC, Abstr ) Mancuso A, Varchetta V, Montagnese F, Campanella C, Brandi R, Vitale M, Soda G, Plasma ctdna RAS/RAF mutations analysis for monitoring overall survival (OS) and heterogeneity in metastatic colorectal cancer patients (mcrc), Gastrointestinal Cancer Symposium, Abstr 702 5) Mancuso A, Varchetta, Campanella C, Montagnese F, et al., Circulating tumor cells (CTC) genotyping in lung cancer diagnosis and decision making, accepted for poster presentation at Biotechnology Meeting Dubai, July 2018 WEB OR MAGAZINE EDUCATIONAL ACTIVITY 1) (Faculty Organization) 2) 3) WEBSITE Villa Margherita Oncology Platform EXTRA MEDICAL EMPLOYMENTS Board Member of CaTheDra Oncological Department, March, 2015-present RESEARCH Founded Protocols Sub-Investigator and Datamanager of the Study Smartfish SF-C002, 2016 Sub-Investigator and Datamanager of the Study Array: A Multicenter, Randomized, Open Label Phase III Study of Encorafenib + Cetuximab +/- Binimetinib vs Irinotecan + Cetuximab with a safety Lead-in of Encorafenib + Binimetinib + Cetuximab in patients with BRAF V600E-mutant Metastatic Colorectal Cancer!5
6 PROFESSIONAL MEMBERSHIPS National and International Member of Italian Association of Medical Oncology, 2015-present Member of Oncological Network, Supportive care NICSO, 2015-present Member of ESMO, 2016-present Member of ASCO, 2016-present Roma 26/01/2018!6
Plasma ctdna RAS/RAF mutations analysis for monitoring overall survival (OS) and heterogeneity in metastatic colorectal cancer patients (mcrc)
Plasma ctdna RAS/RAF mutations analysis for monitoring overall survival (OS) and heterogeneity in metastatic colorectal cancer patients (mcrc) Authors: Andrea Petricca Mancuso, Veronica Varchetta, Fabrizio
More informationTherapeutic Options for Patients with BRAF-mutant Metastatic Colorectal Cancer
Therapeutic Options for Patients with BRAF-mutant Metastatic Colorectal Cancer Axel Grothey, M.D., Professor of Oncology, Clinical and Translational Science Division of Medical Oncology Mayo Clinic, Rochester,
More informationAIOM GIOVANI Perugia, Luglio 2017
AIOM GIOVANI 2017 Perugia, 07-08 Luglio 2017 Scelta delle linee successive nel paziente RAS e BRAF wild-type con particolare accento su nuovi bersagli terapeutici Francesca Battaglin U.O.C. Oncologia Medica
More informationANTI-EGFR IN MCRC? Assoc. Prof. Gerald Prager, Medical University of Vienna, Austria
IS IT TIME TO RE-CHALLENGE ANTI-EGFR IN MCRC? Assoc. Prof. Gerald Prager, Medical University of Vienna, Austria Dr. Andrea Sartore-Bianchi, Oncologia Clinica Molecolare, Niguarda Cancer Center, Milano,
More informationY L L NOTHING BUT THIS. NOTHING IS SIMPLE IN ONCOLOGY.
ID Y L L NOTHING BUT THIS. A NOTHING IS SIMPLE IN ONCOLOGY. WHAT DOES IDYLLA TM M E AN FOR CANCER PATIENTS? High Precision Diagnostics for Personalized Medicine RAPID TREATMENT INITIATION 1 Test results
More informationEuropass Curriculum Vitae
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address Via Gattamelata 64 35128 Padova Telephone(s) +39 049.8215953/5910 E-mail(s) vittorina.zagonel@iov.veneto.it Nationality
More informationFranchi Massimo Piergiuseppe. Policlinico Universitario G Rossi, Azienda Ospedaliera Universitaria Integrata di Verona Verona 2012
Curriculum Vitae Personal information First name(s) / Surname(s) Franchi Massimo Piergiuseppe Telephone(s) 0039 045 8122720 Fax(es) 0039 045 8123394 E-mail(s) Nationality massimo.franchi@univr.it Italian
More informationObjectives. Briefly summarize the current state of colorectal cancer
Disclaimer I do not have any financial conflicts to disclose. I will not be promoting any service or product. This presentation is not meant to offer medical advice and is not intended to establish a standard
More informationLIQUID BIOPSY: TRACKING CANCER
A.R.Ger.On ONLUS SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 prog ram Pierre-Auguste Renoir Chemin montant dans les hautes herbes SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER President Paola
More informationColorectal Cancer in 2017: From Biology to the Clinics. Rodrigo Dienstmann
Colorectal Cancer in 2017: From Biology to the Clinics Rodrigo Dienstmann MOLECULAR CLASSIFICATION Tumor cell Immune cell Tumor microenvironment Stromal cell MOLECULAR CLASSIFICATION Biomarker Tumor cell
More informationMETASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD
METASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD INTRODUCTION Second leading cause of cancer related death in the United States. 136,830 cases in 2014
More informationDescription of Procedure or Service. Policy. Benefits Application
Corporate Medical Policy KRAS, NRAS, BRAF Mutation Analysis and Related File Name: Origination: Last CAP Review: Next CAP Review: Last Review: kras_nras_braf_mutation_analysis_and_related_treatment_in_metastatic_colorectal_cancer
More informationLiquid Biopsy. Jesus Garcia-Foncillas MD PhD. Director
Liquid Biopsy Jesus Garcia-Foncillas MD PhD Director Main issues about liquid biopsies New paradigm: Precision Medicine Heterogeneity & Dynamics Surrogate mirror for the tumor CTCs in colon cancer ctdna:
More informationVIAREGGIO 08/04/11 GENE PROFILING IN CLINICAL ONCOLOGY. 8-9 April 2011 Viareggio, Italy. Chair: M. Aapro, CH
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA VIAREGGIO 08/04/11 GENE PROFILING IN CLINICAL ONCOLOGY 8-9 April 2011 Viareggio, Italy Chair: M. Aapro, CH Dear Colleagues, The European School of Oncology is
More informationColorectal Cancer in the Coming Years: What Can We Expect?
Colorectal Cancer in the Coming Years: What Can We Expect? Clara Montagut, MD, PhD Hospital Universitari del Mar, Barcelona, Spain Memorial Sloan Kettering Cancer Center, New York, United States What Are
More informationUrinary ctdna Platform for Diagnosis and Cancer Treatment Monitoring. Summit August 19,2015
Urinary ctdna Platform for Diagnosis and Cancer Treatment Monitoring Mark G. Erlander, Ph.D., CSO CHI Next Generation Summit August 19,2015 Circulating Tumor DNA (ctdna) Tumor cells Main Advantages of
More informationCurrent Position. Research activities - Publications. Athanasios Kotsakis
Athanasios Kotsakis Athanasios Kotsakis was born in Athens in 1968 and is married with 3 children. He studied Medicine at the University of Athens and continued his training in Internal Medicine at the
More informationReview of the ESMO consensus conference on metastatic CRC Basis strategies ad groups (RAS, BRAF, etc) Michel Ducreux
Review of the ESMO consensus conference on metastatic CRC Basis strategies ad groups (RAS, BRAF, etc) Michel Ducreux 2 ESMO consensus on mcrc 2016 Chairs: Co-Chairs of working groups E Van Cutsem A Sobrero
More informationColorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital
Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?
More informationOctober 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference
The premier conference for annual updates in lung cancer 23rd Annual Conference October 12 13, 2018 New York Marriott Marquis New York, New York Reserve your place today: thoraciccancermeeting.com Perspectives
More informationCURRENT STANDARD OF CARE OF COLORECTAL CANCER: THE EVOLUTION OF ESMO CLINICAL PRACTICE GUIDELINES
CURRENT STANDARD OF CARE OF COLORECTAL CANCER: THE EVOLUTION OF ESMO CLINICAL PRACTICE GUIDELINES Fortunato Ciardiello ESMO Past-President 2018-2019 Dipartimento di Medicina di Precisione Università degli
More informationCURRICULUM VITAE PERSONAL DETAILS: RAHAL, MOHAMED
PERSONAL DETAILS: CURRICULUM VITAE NAME: RAHAL, MOHAMED MARITAL STATUS: ADDRESS: Married, 3 children King Fahad Specialist Hospital Oncology Department PO BOX 14563 DAMMAM 31434 Kingdom of Saudi Arabia
More informationBasket Trials: Features, Examples, and Challenges
: Features, s, and Challenges Lindsay A. Renfro, Ph.D. Associate Professor of Research Division of Biostatistics University of Southern California ASA Biopharm / Regulatory / Industry Statistics Workshop
More informationOHTAC Recommendation. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer
OHTAC Recommendation KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer Presented to the Ontario Health Technology Advisory Committee in August, 2010 December 2010 Issue Background In February
More informationESMO ACROSS ONCOLOGY. WORLDWIDE. Josep Tabernero. ESMO President. ESMO SUMMIT MIDDLE EAST Friday, 6 th April 2018
ESMO ACROSS ONCOLOGY. WORLDWIDE Josep Tabernero ESMO President ESMO SUMMIT MIDDLE EAST Friday, 6 th April 2018 ESMO IN A NUTSHELL Europe s leading Medical Oncology Society ESMO is the leading European
More informationInfographic (right): ESMO 2014 record breaking Congress
ESMO 2014 Congress Scientific Meeting Report Precision Medicine in Cancer Care 26-30 September 2014 Madrid, Spain Summary The European Society for Medical Oncology (ESMO) Congress, held September 26 to
More informationCURRICULUM VITAE. Date of birth July 30th, 1960 PERSONAL INFORMATIONS. Curriculum vitae of Alberto Matteelli pag. 1/6
E U R O PA S S CURRICULUM VITAE PERSONAL INFORMATIONS Surname/First name Alberto Matteelli Address Passirano (Brescia) Piazza Europa 24, ZIP 25050 Telephone (s) +39.030.3995802 (office) Mobile: +30.339.3344033
More informationMolecular Testing Updates. Karen Rasmussen, PhD, FACMG Clinical Molecular Genetics Spectrum Medical Group, Pathology Division Portland, Maine
Molecular Testing Updates Karen Rasmussen, PhD, FACMG Clinical Molecular Genetics Spectrum Medical Group, Pathology Division Portland, Maine Keeping Up with Predictive Molecular Testing in Oncology: Technical
More informationProf. Pietro Ruggieri CURRICULUM VITAE. Full Professor and Chairman of the Department of Orthopedics and Orthopedic Oncology at University of Padova
Prof. Pietro Ruggieri CURRICULUM VITAE Date of birth 04/26/1958 Title Full Professor and Chairman of the Department of Orthopedics and Orthopedic Oncology at University of Padova Current Assignment Professor
More informationFirst phase III data on Roche s TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress
Media Release Basel, 03 October 2016 First phase III data on Roche s TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress Superiority results from the phase
More informationColorectal Cancer: Critical review
AIOM POST-ASCO 2018 Updates and Review from Chicago Milano, June 15-16, 2018 Colorectal Cancer: Critical review Alfredo Falcone, MD Department of Oncology and Translational Medicine University of Pisa
More informationPancreatic Cancer: Medical Therapeutic Approaches
Pancreatic Cancer: Medical Therapeutic Approaches Vincent J Picozzi MD MMM Virginia Mason Medical Center Seattle WA 1 Pancreatic cancer is the hardest cancer of all to treat Pancreatic cancer: Why so difficult
More informationHow is Merck supporting innovation in oncology?
How is Merck supporting innovation in oncology? We sponsor research and advanced medical education globally, reflecting our commitment to science, education and patient care We support the development
More informationESMO Clinical Practice Guidelines. ECCO GUIDELINES FORUM Brussels, November 27
ESMO Clinical Practice Guidelines ECCO GUIDELINES FORUM Brussels, November 27 ESMO Clinical Practice Guidelines ESMO Consensus Conferences ESMO Pocket & Mobile Guidelines ESMO Guides for Patients History
More informationBristol-Myers Squibb Independent Medical Education
Bristol-Myers Squibb Independent Medical Education Request for Educational Support (RFE) Date August 10, 2017 RFE Requestor Information RFE Code Name: Maria Deutsch, MS, PharmD, RPh Title: IME Specialist,
More informationEvolution of the individualized treatment landscape for advanced NSCLC
IASLC Asia Pacific Lung Cancer Conference (APLCC 2016) 13-15 May 2016, Chiang Mai, Thailand Evolution of the individualized treatment landscape for advanced NSCLC Chaired by Tony Mok Empress Grand Hall,
More information6-8 July Naples, Italy
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Metastatic colorectal cancer: from disease biology to clinical management 6-8 July 2016 - Naples, Italy Metastatic colorectal cancer: from disease biology
More informationCURRICULUM VITAE MAIN POST DEGREE EDUCATION AND CREDIT 1/3
CURRICULUM VITAE Name: Bruno Family Name : Violante Date of birth: March 27 th, 1961 Education : 1987 Naples University Degree in Medicine and Surgery 1992 Firenze University Degree in Orthopaedic Cum
More informationAnnounce Expected Initiation of an Investigator-Initiated, Randomized, Phase 2, Multicenter Trial of Ficlatuzumab and Cetuximab in HNSCC in 2H 2017
AVEO Oncology and Biodesix Announce Results from Two Investigator-Sponsored Phase 1 Studies of HGF Targeted Antibody Ficlatuzumab at the 2017 ASCO Annual Meeting Announce Expected Initiation of an Investigator-Initiated,
More informationPharmacy Management Drug Policy
11/13, 10/12, 11/11, 1, 6/10, Page 1 of 5 DESCRIPTION: Cetuximab is a recombinant humanized monoclonal antibody that binds specifically to the extracellular domain of the human epidermal growth factor
More informationCURRICULUM VITAE. Chiyoko Kobayashi Frank, Ph.D. Adjunct Faculty, School of Psychology, Fielding Graduate University
CURRICULUM VITAE Chiyoko Kobayashi Frank, Ph.D Adjunct Faculty, School of Psychology, Fielding Graduate University New York Board Certified Psychologist Email: ckobayashi@email.fielding.edu Professional
More informationCURRICULUM VITAE. Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital
CURRICULUM VITAE Name: Position: Address: Edgar Pierluissi Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital 1001 Potrero Avenue
More informationDALLA CAPECITABINA AL TAS 102
DALLA CAPECITABINA AL TAS 102 Milano 29 settembre 2016 LE PROSPETTIVE NELLA RICERCA Armando Santoro Humanitas Cancer Center THE 1,2.AND 3 LINE CHEMOTHERAPY IN CRC M BEVACIZUMAB AFLIBERCET RAS wt RAS mu
More informationCLAUDIA RODELLA CURRICULUM VITAE
CLAUDIA RODELLA CURRICULUM VITAE PERSONAL INFORMATION: Date of birth: 16 th May 1988 Place of birth: Brescia (BS) - Italy Nationality: Italian Phone: +39 0303501594 E-mail: claudia.rodella@gmail.com claudia.rodella@cognitiveneuroscience.it
More informationExamples of Selection Criteria for the EAMA
Examples of Selection Criteria for the EAMA Category 1 Category 2 Category 3 MD members of the staff with a PhD degree and experience in clinical work, research and education of students of departments
More informationVectibix. Vectibix (panitumumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.85 Subject: Vectibix Page: 1 of 5 Last Review Date: December 2, 2016 Vectibix Description Vectibix
More informationESMO Translational Research Fellowship (November 2015 November 2017) Lisa Derosa FINAL REPORT
ESMO Translational Research Fellowship (November 2015 November 2017) Lisa Derosa FINAL REPORT Host Institute: Institute Gustave Roussy, Villejuif, France Mentor: Dr. Bernard Escudier Project title: The
More informationEasy Breathing. An asthma management program for Pediatricians, Primary Care Practitioners, and Family Practitioners.
Easy Breathing An asthma management program for Pediatricians, Primary Care Practitioners, and Family Practitioners. The Asthma Center The Asthma Center at Connecticut Children s Medical Center was established
More informationLa biopsia liquida. Aldo Scarpa. Anatomia Patologica e ARC-NET Centro di Ricerca Applicata sul Cancro
La biopsia liquida Aldo Scarpa Anatomia Patologica e ARC-NET Centro di Ricerca Applicata sul Cancro Azienda Ospedaliera Universitaria Integrata di Verona Obstacles to precision oncology Genomic heterogeneity
More informationUNIVERSITY OF GENOVA CURRICULUM VITAE
UNIVERSITY OF GENOVA CURRICULUM VITAE Genova, 07.06.2013 NAME: MOHAMAD MAGHNIE CURRENT TITLE & DEPARTMENT: Associate Professor of Pediatrics Department of Pediatrics, School of Medicine Director, Pediatric
More informationE U R O P E A N PERSONAL INFORMATION. Name Address Telephone Fax MATTEO RAVAIOLI. Date of birth WORK EXPERIENCE
E U R O P E A N C U R R I C U L U M V I T A E F O R M A T PERSONAL INFORMATION Name Address Telephone Fax E-mail MATTEO RAVAIOLI Nationality Italian Date of birth WORK EXPERIENCE 200-2009: surgeon staff
More informationCirculating Tumor DNA in GIST and its Implications on Treatment
Circulating Tumor DNA in GIST and its Implications on Treatment October 2 nd 2017 Dr. Ciara Kelly Assistant Attending Physician Sarcoma Medical Oncology Service Objectives Background Liquid biopsy & ctdna
More informationAhu Gökçe, Ph.D. Department of Psychology Kadir Has University
1 CURRICULUM VITAE Ahu Gökçe, Ph.D. Department of Psychology Kadir Has University ahu.gokce@khas.edu.tr EDUCATION 2010 2013: Doctor of Philosophy Department of General and Experimental Psychology, & Munich
More informationResident Senior, Dept. of Neurosurgery Notre-Dame Hospital University of Montreal, Canada, under the guidance of prof. Jules Hardy.
Prof. Giulio Maira ACADEMY DEGREES 1968 October 1972 Degree in Medicine and Surgery, Catholic University School of Medicine Rome, Italy (magna cum laude) Specialist in Neurosurgery, University of Genoa,
More informationCurriculum Vitae Europass
Curriculum Vitae Europass PERSONAL INFORMATION Name Work Address Scorsetti Marta SCRMRT67A57G558T Radiotherapy and Radiosugery Department, Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano (MI),
More informationImmunotherapy in Colorectal cancer
Immunotherapy in Colorectal cancer Ahmed Zakari, MD Associate Professor University of Central Florida, College of Medicine Medical Director, Gastro Intestinal Cancer Program Florida Hospital Cancer Institute
More informationLa biopsia liquida dei tumori: il viaggio. Paola Gazzaniga Liquid Biopsy Unit Dept. Molecular Medicine Sapienza University of Rome
La biopsia liquida dei tumori: il viaggio Paola Gazzaniga Liquid Biopsy Unit Dept. Molecular Medicine Sapienza University of Rome Must Know Necessary Travel Tips There is lack of drugs to treat all the
More informationINDICATION: COMPENDIA TRANSPARENCY TRACKING FORM
COMPENDIA TRANSPARENCY TRACKING FORM DRUG: Panitumumab INDICATION: Metastatic colorectal cancer, wild-type KRAS mutation, first-line therapy, in combination with infusional fluorouracil, leucovorin, and
More informationOMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors
OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors Jakob Dupont MD MA CMO, SVP: OncoMed Pharmaceuticals Adjunct Clinical Faculty: Stanford University
More informationASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer
ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer Joseph Jacobson, MD Chair, QOPI Steering Committee Salem MA October 6, 2009 American Society of Clinical
More informationColon cancer: Highlights. Filippo Pietrantonio Istituto Nazionale dei Tumori di Milano
Colon cancer: Highlights Filippo Pietrantonio Istituto Nazionale dei Tumori di Milano Agenda 1) Metastatic colorectal cancer First-line treatment molecularly unselected: FOLFOXIRI-bev (CHARTA trial) Later-line
More informationName of Policy: Panitumumab, Vectibix
Name of Policy: Panitumumab, Vectibix Policy #: 369 Latest Review Date: June 2014 Category: Pharmacology Policy Grade: B Background/Definitions: As a general rule, benefits are payable under Blue Cross
More informationJY Douillard MD, PhD Professor of Medical Oncology
Colorectal Cancer ESMO Preceptorship Program Prague May 22-23rd 2014 Review of the ESMO Consensus Conference on metastatic colo-rectal cancer Basic strategy and groups (RASwt/mut, BRAF mut) JY Douillard
More informationAACE History. ! Founded in 1991 to serve as the active voice for clinical endocrinologists
AACE History! Founded in 1991 to serve as the active voice for clinical endocrinologists! Providing practicing clinical endocrinologists an avenue for the study of the scientific, social, political, and
More informationRoche Investor Relations ASCO Planner 2017
Roche Investor Relations ASCO Planner 2017 Saturday, June 3 Session Title: Lung Cancer Non-Small Cell Metastatic Date: Sat, June 3 Time: 8:00 AM 11:30 AM Speaker Name: Ibiayi Dagogo-Jack, MD; Yuichi Takiguchi,
More informationDaniele Santini University Campus Bio-Medico Rome, Italy
Daniele Santini University Campus Bio-Medico Rome, Italy Anti EGFR therapy and colorectal cancer Cetuximab or Panitumumab Adapted from Ciardiello F. and Tortora G. NEJM 2008;358:1160-74 Who will benefit
More informationCURRICULUM VITAE. Brynie Slome Collins, M.D. Department of Gastroenterology and Nutrition 4650 Sunset Blvd MS 78 Los Angeles, Ca 90027
A. PERSONAL INFORMATION CURRICULUM VITAE Name in Full Business Address Brynie Slome Collins, M.D. Department of Gastroenterology and Nutrition 4650 Sunset Blvd MS 78 Los Angeles, Ca 90027 Business Phone
More informationSergio Bracarda MD, Head, Department of Oncology Azienda USL Toscana Sud-Est Istituto Toscano Tumori (ITT) Ospedale San Donato Arezzo, Italy
Sergio Bracarda MD, Head, Department of Oncology Azienda USL Toscana Sud-Est Istituto Toscano Tumori (ITT) Ospedale San Donato Arezzo, Italy Milano, 3 marzo 2017 Prostata: Castration resistant HIGHLIGHTS
More informationImmunotherapy for dmmr metastatic colorectal cancer. Prof.dr. Kees Punt Dept. Medical Oncology AUMC
Immunotherapy for dmmr metastatic colorectal cancer Prof.dr. Kees Punt Dept. Medical Oncology AUMC Active specific immunotherapy (ASI) in stage II-III colon cancer Vaccination with autologous tumor + BCG
More informationQué hemos aprendido hasta hoy? What have we learned so far?
Qué hemos aprendido hasta hoy? What have we learned so far? Luís Costa Hospital de Santa Maria & Instituto de Medicina Molecular Faculdade de Medicina de Lisboa Disclosures Research Grants: Amgen; Novartis;
More informationCurriculum Vitae Europass
Curriculum Vitae Europass Personal information Name and surname Nicoletta Zerman Address Piazzale Ludovico Scuro 10 VERONA Telephone numbers +39 045 8027437 mobile 335 1804333 Fax 045 8027437 E-mail Nicoletta.zerman@univr.it
More informationLa strategia terapeutica per il trattamento del carcinoma del colon-retto metastatico
VI Corso Nazionale Eventi Formativi AIOM-SIAPEC Roma,15 Giugno 2016 La strategia terapeutica per il trattamento del carcinoma del colon-retto metastatico Francesco Di Costanzo Direttore SC Oncologia Medica
More informationFellow in Nephrology at University of California, San Francisco 7/1/1982-6/30/1984
Curriculum Vitae Haseeb I. Al-Mufti, MD 13939 E 14 th St, Suite 170 San Leandro, CA 94578-2613 660 4 th St, # 349 San Francisco, CA 94107-1618 Office (510) 483-2480 Fax (510) 483-4286 Email: halmufti@renalassociates.org
More informationHeavilyTreated mcrc..whats next?
ESMO Preceptorship Programme Gastrointestinal Cancer 20-22 October 2016,Singapore Dr Surendra Pal Chaudhary Dept of Medical Oncology Dr BR Ambedkar Instituite Rotary Cancer Hospital All India Institute
More informationOncotype DX DX : Colon Cancer Assay: Scientific Publications and Presentations.
Oncotype DX DX : Colon Cancer Assay: Scientific Publications Scientific and Presentations Publications and Presentations www.oncotypedx.com Oncotype DX : Scientific Publications and Presentations A Tool
More informationCurriculum Vitae Gianluigi Zanusso, M.D., Ph.D.
Curriculum Vitae Gianluigi Zanusso, M.D., Ph.D. Place and date of birth: Desenzano del Garda, September 21, 1963 Citizenship: Italian Affiliation: Department of Neurosciences, Biomedicine and Movement
More informationCURRICULUM VITAE. Chiyoko Kobayashi Frank, Ph.D. Adjunct Faculty, School of Psychology, Fielding Graduate University
CURRICULUM VITAE Chiyoko Kobayashi Frank, Ph.D Adjunct Faculty, School of Psychology, Fielding Graduate University Psychologist, Center for Cognition and Communication Email: ckobayashi@fielding.edu Professional
More informationValidated and promising predictive factors in mcrc: Recent updates on RAS testing Fotios Loupakis, MD PhD
Validated and promising predictive factors in mcrc: Recent updates on RAS testing Fotios Loupakis, MD PhD U.O. Oncologia 2 Universitaria Azienda Ospedaliero-Universitaria Pisana Pisa, Italy Learning Objectives
More informationSofia Aroca, Paris France
Sofia Aroca, Paris France University Qualifications 1985 Doctor in dental surgical medicine 1991 Post-graduate of dental biomaterials. University Paris VII, France 1992 Certificate of Periodontology. University
More informationCARCINOMA DEL COLON-RETTO: COSA DICONO LE LINEE GUIDA. Dr.ssa Foltran Luisa Oncologia medica Pordenone
CARCINOMA DEL COLON-RETTO: COSA DICONO LE LINEE GUIDA Dr.ssa Foltran Luisa Oncologia medica Pordenone Convegno Regionale AIOM FVG, Palmanova, 14 Maggio 2016 COLORECTAL CANCER FOLLOW-UP Objectives Intensive
More informationColon cancer: ASCO poster review. Alfonso De Stefano MD, PhD SC Oncologia Clinica Sperimentale Addome
Colon cancer: ASCO poster review Alfonso De Stefano MD, PhD SC Oncologia Clinica Sperimentale Addome a.destefano@istitutotumori.na.it 255 poster examined: my selection Clinical Practice Translational &
More informationNewsletter. What s inside: ISSUE 3 SEPTEMBER 2017
Newsletter ISSUE 3 SEPTEMBER 2017 I PE WELCOME TO THE THIRD NEWSLETTER OF THE RIBURST STUDY (REDUCING THE INTERNATIONAL BURDEN OF STROKE USING MOBILE TECHNOLOGY) Progress of the Study The study is progressing
More informationThird Line and Beyond: Management of Refractory Colorectal Cancer
Third Line and Beyond: Management of Refractory Colorectal Cancer George A. Fisher MD PhD Stanford University 1 Overview Defining the chemo refractory and intolerant Agents approved in 3 rd line setting
More informationMEETING SUMMARY ESMO 2018, Munich, Germany. Dr. Jenny Seligmann University of Leeds, UK HIGHLIGHTS ON COLORECTAL CANCER
MEETING SUMMARY ESMO 2018, Munich, Germany Dr. Jenny Seligmann University of Leeds, UK HIGHLIGHTS ON COLORECTAL CANCER DISCLAIMER Please note: The views expressed within this presentation are the personal
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationMUTATION TEST CE IVD. ctnras-braf FEATURES
ctnras-braf CE IVD TECHNICAL SHEET IDYLLA ctnras-braf MUTATION TEST The Idylla ctnras-braf Mutation Test, performed on the Biocartis Idylla System, is an in vitro diagnostic test for the qualitative detection
More informationArray BioPharma Jefferies 2016 Global Healthcare Conference. June 9, 2016
Array BioPharma Jefferies 216 Global Healthcare Conference June 9, 216 Safe Harbor Statement 2 Forward-looking statements made in the course of this presentation are made pursuant to the safe harbor provisions
More informationImmunotherapy for Breast Cancer. Aurelio B. Castrellon Medical Oncology Memorial Healthcare System
Immunotherapy for Breast Cancer Aurelio B. Castrellon Medical Oncology Memorial Healthcare System Conflicts Research support : Cascadian therapeutics, Puma biotechnology, Odonate therapeutics, Pfizer,
More informationIf multiple KRAS mutation tests have been performed, refer to the most recent test results.
Measure #452 (NQF 1860): Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies National Quality Strategy
More informationOVERVIEW DAGLI STUDI CLINICI CON NAB-PACLITAXEL Studio GAP. Alberto Zaniboni. Oncologia Medica, Fondazione Poliambulanza Brescia
OVERVIEW DAGLI STUDI CLINICI CON NAB-PACLITAXEL Studio GAP Alberto Zaniboni Oncologia Medica, Fondazione Poliambulanza Brescia A Phase II randomized trial comparing a combination of Abraxane and Gemcitabine
More informationAdjuvant/neoadjuvant systemic treatment of colorectal cancer
5th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology Belgrade, June 19 th 2018 Adjuvant/neoadjuvant systemic treatment of colorectal cancer Carlotta Antoniotti Polo Oncologico
More informationSee how you can guide the path her cancer takes
See how you can guide the path her cancer takes 1 Idylla : easy, rapid and accurate molecular medicine for every patient Paola Valente Strategic Marketing Biocartis 6th meeting on external quality assessment
More informationCURRICULUM VITAE. Meagan B. Farmer, MS, CGC, MBA
CURRICULUM VITAE Meagan B. Farmer, MS, CGC, MBA EDUCATION 2015-2017 M.B.A. Concentrations: Healthcare and Information Systems Management 2010-2012 M.S. Genetic Counseling University of North Carolina at
More informationColorectal Cancer: Lumping or Splitting? Jimmy J. Hwang, MD FACP Levine Cancer Institute Carolinas HealthCare System Charlotte, NC
Colorectal Cancer: Lumping or Splitting? Jimmy J. Hwang, MD FACP Levine Cancer Institute Carolinas HealthCare System Charlotte, NC 2 Epidemiology Colorectal Cancer is the 2 nd Leading Cause of Cancer-related
More informationBIOGRAPHY (Date of Birth: 12/09/1972).
Curriculum vitae Prof. Massimo Miglioretti Associate Professor Department of Psychology University of Milan-Bicocca (ITALY) e-mail: massimo.miglioretti@unimib.it BIOGRAPHY (Date of Birth: 12/09/1972).
More informationClinicalTrials.gov Protocol and Results Registration System (PRS) Receipt Release Date: 09/30/2015. ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol and Results Registration System (PRS) Receipt Release Date: 09/30/2015 ClinicalTrials.gov ID: NCT01378962 Study Identification Unique Protocol ID: ML25514 Brief Title: A Study
More informationPositions held: Education/Professional Experience: Curriculum vitae
Curriculum vitae Alia Mohamed Ali Attia, M.B.B.cH., M.Sc., MD. Associate Professor of Radiation Oncology at South Egypt Cancer Institute, Assiut University, Assiut, Egypt First name: Alia Middlesbrough
More informationDISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,
More informationPrognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients. Bruno Vincenzi Università Campus Bio-Medico di Roma
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Bruno Vincenzi Università Campus Bio-Medico di Roma Colorectal cancer 3 rd most common cancer worldwide Approximately
More informationDeveloping effective ctdna testing services for lung cancer. Executive summary
Developing effective ctdna testing services for lung cancer Executive summary September 2017 Authors: Laura Blackburn, Leila Luheshi, Sandi Deans, Mark Kroese, Hilary Burton Acknowledgements: The PHG Foundation
More information